Loading...
Healthia Limited
HLA.AX•ASX
Healthcare
Medical - Care Facilities
A$1.79
A$0.003(0.17%)

The company's financials show resilient growth, with revenue advancing from $61.82M in Q1 2022 to $64.45M in Q4 2022. Gross profit remained healthy with margins at 30% in Q4 2022 compared to 30% in Q1 2022. Operating income hit $7.36M last quarter, sustaining a consistent 11% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $9.11M. Net income rose to $721500.00, while earnings per share reached $0.005. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan